Brent Atwood - Net Worth and Insider Trading

Brent Atwood Net Worth

The estimated net worth of Brent Atwood is at least $10,088 dollars as of 2024-11-08. Brent Atwood is the 10% Owner of GlobeStar Therapeutics Corp and owns about 25,220,000 shares of GlobeStar Therapeutics Corp (GSTC) stock worth over $10,088. Details can be seen in Brent Atwood's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brent Atwood has not made any transactions after 2019-08-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Brent Atwood

To

Brent Atwood Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brent Atwood owns 1 companies in total, including GlobeStar Therapeutics Corp (GSTC) .

Click here to see the complete history of Brent Atwood’s form 4 insider trades.

Insider Ownership Summary of Brent Atwood

Ticker Comapny Transaction Date Type of Owner
GSTC GlobeStar Therapeutics Corp 2020-02-25 10 percent owner

Brent Atwood Latest Holdings Summary

Brent Atwood currently owns a total of 1 stock. Brent Atwood owns 25,220,000 shares of GlobeStar Therapeutics Corp (GSTC) as of August 13, 2019, with a value of $10,088.

Latest Holdings of Brent Atwood

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GSTC GlobeStar Therapeutics Corp 2019-08-13 25,220,000 0.00 10,088

Holding Weightings of Brent Atwood


Brent Atwood Form 4 Trading Tracker

According to the SEC Form 4 filings, Brent Atwood has made a total of 0 transactions in GlobeStar Therapeutics Corp (GSTC) over the past 5 years. The most-recent trade in GlobeStar Therapeutics Corp is the acquisition of 12,176,719 shares on August 13, 2019, which cost Brent Atwood around $243,534.

Insider Trading History of Brent Atwood

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brent Atwood Trading Performance

GuruFocus tracks the stock performance after each of Brent Atwood's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brent Atwood is -50%. GuruFocus also compares Brent Atwood's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brent Atwood within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Brent Atwood's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Brent Atwood

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -50 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -52.77 LIMIT LIMIT LIMIT LIMIT LIMIT

Brent Atwood Ownership Network

Ownership Network List of Brent Atwood

No Data

Ownership Network Relation of Brent Atwood

Insider Network Chart

Brent Atwood Owned Company Details

What does GlobeStar Therapeutics Corp do?

Who are the key executives at GlobeStar Therapeutics Corp?

Brent Atwood is the 10 percent owner of GlobeStar Therapeutics Corp. Other key executives at GlobeStar Therapeutics Corp include director & CEO James C Katzaroff , CFO Robert Chicoski , and director & CEO & Pres. & Secr. & Treas. Alex K Blankenship .

GlobeStar Therapeutics Corp (GSTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of GlobeStar Therapeutics Corp (GSTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GlobeStar Therapeutics Corp (GSTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

GlobeStar Therapeutics Corp (GSTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

GlobeStar Therapeutics Corp Insider Transactions

No Available Data

Brent Atwood Mailing Address

Above is the net worth, insider trading, and ownership report for Brent Atwood. You might contact Brent Atwood via mailing address: 5000 Riverside Dr Ste100e, Irving Tx 75039.